Ventri-Cath Catheter (5F, 12E, 15mm, DField, Straight, 122cm)

Overview:

The VENTRI-CATH-515S Ventri-Cath Catheter (5F, 12E, 15mm, DField, Straight, 122cm) is an evolution of multi-segment pressure-volume (PV) catheters for complete cardiac function assessment in a continuously beating, intact heart of large animals (including dog, pig and sheep). It has a single catheter with a pressure sensor and electrodes that allows direct insertion into the heart with no effect on normal functioning of heart.

The Ventri-Cath Catheter uses a new lighter connector that combines the pressure and volume outputs into a single connector. Therefore, the catheter requires the CEC-10PV PV Extension Cable (VC to MPVS Ultra, 10ft), which is purchased separately for connection to the 880-0168 MPVS Ultra Pressure-Volume Unit (small or large animals).

When used with the 880-0168 MPVS Ultra Pressure-Volume Unit (large & small animals), the VC Catheter provides simultaneous measurement high-fidelity real-time pressure, up to seven segments of relative volume signals and an intra-cardiac ECG signal for monitoring and analysis of ventricular function.

With the CEC-10PV PV Extension Cable (VC to MPVS Ultra, 10ft), the VC Catheter can also be used with the PL3516B49 MPVS Ultra Foundation System.

The Ventri-Cath Catheter provides high quality and integrity yet cost effective alternative to SPC-550 and SPC-560 series PV catheters.

Calibration
A Pressure Gauge kit which provides the necessary items to calibrate the pressure transducers is available. Please contact your nearest ADInstruments representative for any further information.

Features:

• 5F Multi-Segmented, Dual Field, Pressure-Volume catheter
• Straightl tip
• Effective length: 122cm
• Single pressure sensor located in the center of the catheter, between the 4th and 5th electrodes
• For ventricular volume the catheter has twelve electrodes with a spacing of 15mm
• Single low profile light weight connector that combines the pressure and volumes outputs

Applications:

It can be used in studies including:

• Cardiomyopathy
• Hypertrophy
• Cardiac Resynchronization Therapy (CRT)
• LVAD Device Development
• Valve Diseases including Stenosis and Regurgitation
• Toxicology & Pharmacology
• Heart Transplants
   

Specifications: